NAYA Company Profile and Key Details

NAYA has shown mixed momentum, gaining 14.58% over the past week and -61.81% over the past quarter, though year-to-date performance is down -77.37%. Short-term trend indicators are bullishly aligned (SMA20 11.74%, SMA50 -25.29%, SMA200 -71.13%). The stock’s 14-day RSI is 47.62 (neutral), while the ATR of 0.37 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -87.09% below its high and over 59.42% above its low.

NAYA Biosciences, Inc. generated EPS of -$30.54 over the past year. Five-year average earnings growth is 17.42%. Wall Street analysts project EPS growth of 50.85% annually over the next five years. NAYA Biosciences, Inc. earnings surprise history is a mixed track record. The quarter that ended April 22, 2025, missed forecasts by -72.13%. The prior quarter beat by 366.67%. Over the last six quarters, Apple has recorded several small beats. These include -386.21% in April 16, 2024.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

NAYA Biosciences, Inc. (NASDAQ:NAYA) shares are down -77.37% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows NAYA Biosciences, Inc. trading at a premium to the broader market with a P/E of -0.07. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $2.00, suggesting 12.36% upside. Our AI forecast model points to short-term weakness (-100.0% over two weeks), a medium-term rise (1210.11% over three months), and a longer-term loss (-80.9% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that NAYA Biosciences, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -100.0%, with price expected at $0.00 by June 05, 2025, within a range of $0.00 to $4.26 3-Month Outlook: Projected rise of 1210.11%, reaching $23.32 by July 30, 2025, with a range of $22.56 to $24.07. 1-Year Outlook: Projected loss of -80.9%, with price at $0.34 by May 01, 2026, within a range of $0.00 to $1.09.

NAYA Biosciences, Inc. trades at a P/E ratio of -0.07, slightly below the S&P 500 average, with a price-to-sales ratio of 0.22 and a price-to-book ratio of 0.05 suggesting the stock is closer to book value. The P/FCF stands at -0.46, also above market averages.

NAYA Biosciences, Inc. (NASDAQ:NAYA) closed at $2.20 USD, gaining $0.17 (8.37%) from the previous close of $2.03. The stock is currently mid-range between its 52-week high and low $1.38 and $17.04. With a market capitalization of about $1.47 million, NAYA Biosciences, Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~2.04). Key stats such as the average daily volume over the past year has been around 1.56 million shares, volume is running light vs its 52-week average. Headquartered in Sarasota, None, NAYA Biosciences, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Steven M. Shum, the company employs approximately 30 people and listed since November 02, 2020. INVO Bioscience operates as a medical device company, focusing on the development and provision of tools and solutions for diagnosing infertility.